Donald Royce Sutton, RPH in Beach, ND - Pharmacist

Donald Royce Sutton, RPH is a Pharmacist based in Beach, North Dakota. Donald Royce Sutton is licensed to practice in Arizona (license number 6522) and his current practice location is 90 6th St Sw, Beach, North Dakota. He can be reached at his office (for appointments etc.) via phone at (928) 853-9616.

NPI number for Donald Royce Sutton is 1639662182 and his current mailing address is 90 6th St Sw, Beach, North Dakota. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1639662182.

Contact Information

	Donald Royce Sutton, RPH
	90 6th St Sw, Beach, ND 58621-4004
	(928) 853-9616
	Not Available

Healthcare Provider's Profile

Full Name	Donald Royce Sutton
Gender	Male
Speciality	Pharmacist
Location	90 6th St Sw, Beach, North Dakota
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1639662182
Provider Enumeration Date: 06/10/2018
Last Update Date: 06/10/2018

Medical Identifiers

Medical identifiers for Donald Royce Sutton such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1639662182	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	046676 (New York)	Secondary
183500000X	Pharmacist	6522 (Arizona)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Donald Royce Sutton is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Donald Royce Sutton, RPH 90 6th St Sw, Beach, ND 58621-4004 Ph: (928) 853-9616	Donald Royce Sutton, RPH 90 6th St Sw, Beach, ND 58621-4004 Ph: (928) 853-9616

News Archive

Study shows how high glucose damages the vascular system

Diabetes, which is marked by increased glucose levels in the body, eventually leads to certain complications, including cardiovascular disease. Now, a new study shows a cellular connection between diabetes and blood vessel narrowing that boosts one's risk of chronic and potentially fatal health conditions, including stroke and heart disease.

ASA commends FDA for identifying root causes and solutions to drug shortages

On October 29, the inter-agency Drug Shortages Task Force led by the U.S. Food and Drug Administration issued a report titled "Drug Shortages: Root Causes and Potential Solutions" at the request of Congress.

Shared decision-making tool cuts antibiotic use

Patients are much less likely to take antibiotics for an acute respiratory infection if they consult a family doctor who has been trained in shared decision-making, report researchers from Canada.

Can-Fite's CF102 drug gets approval in Israel for patient with hepatocellular carcinoma

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that the Israeli Ministry of Health has approved the use of its drug CF102 for a patient with hepatocellular carcinoma, the most common form of liver cancer, under the country's Compassionate Use Program.

Donald Royce Sutton, RPH - Pharmacist in Beach, ND